30 results
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
19 Jan 22
Entry into a Material Definitive Agreement
9:01am
and all losses, claims, damages, liabilities, fees, costs, expenses (including fees, disbursements and costs of counsel and other skilled professionals
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
5 Apr 21
Sorrento eNTERS INTO MERGER agreement tO acquire late-stage oncology company acea therapeutics
9:11am
(including fees, disbursements and costs of counsel and other skilled professionals and in connection with seeking recovery from insurers), judgments
8-K
EX-99.1
majia04
17 Jun 19
Other Events
9:22am
8-K
EX-2.1
f6qdx3du8c8juzxtdz
22 Mar 19
Entry into a Material Definitive Agreement
7:00am
424B5
81pydtui0n27zf1xl4
14 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
yqondaylj92c6i45q20
12 Apr 17
Prospectus supplement for primary offering
12:00am